BRIEF-Redhill Biopharma says preparations continue for confirmatory phase III study with RHB-105 for treatment of H. Pylori infection
August 11, 2016 at 11:03 AM EDT
* Confirmatory phase iii study, along with results from first phase iii study, data from supportive pk program to support nda for rhb-105
